SBI Securities’s Evoke Pharma EVOK Stock Holding History

SBI Securities’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-76	Closed	-$378	–	4097
2025 Q3	$378	Buy	76 +1	+1%	+$5	﹤0.01%	3085
2025 Q2	$195	Hold	75	–	–	﹤0.01%	3315
2025 Q1	$206	Hold	75	–	–	﹤0.01%	3216
2024 Q4	$332	Buy	+75	New	+$374	﹤0.01%	3043

SBI Securities's EVOK Position: Q4 2025 in Review

SBI Securities sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 76 shares — an estimated $378 sold.

SBI Securities first reported a position in EVOK in Q4 2024 and held it in 4 quarters. The position peaked at $378 in Q3 2025. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.

SBI Securities reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 76 Evoke Pharma shares in Q4 2025, an estimated $378.
SBI Securities first reported a position in Evoke Pharma in Q4 2024 and held it in 4 quarters.
SBI Securities's Evoke Pharma position peaked at $378 in Q3 2025.
0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.